Showing results (701-710 of 1,988) with videos related to

Sort By:
Pageof 199
Prostate Cancer and Prostatic Diseases|October 4, 2018
Prostate Imaging Compared to Transperineal Ultrasound-guided biopsy for significant prostate cancer Risk Evaluation (PICTURE): a prospective cohort validating study assessing Prostate HistoScanningLucy A M Simmons, Abi Kanthabalan, Manit Arya, et al.
Prostate Cancer and Prostatic Diseases|May 1, 2019
Measuring the unmeasurable: automated bone scan index as a quantitative endpoint in prostate cancer clinical trialsJose Mauricio Mota, Andrew J Armstrong, Steven M Larson, et al.
Prostate Cancer and Prostatic Diseases|April 19, 2019
Assessing the relationship between statin use and oncologic outcomes among men electing active surveillance for localized prostate cancerYaw A Nyame, Lamont Wilkins, Daniel J Greene, et al.
Prostate Cancer and Prostatic Diseases|March 29, 2022
Inherited risk assessment and its clinical utility for predicting prostate cancer from diagnostic prostate biopsiesJianfeng Xu, W Kyle Resurreccion, Zhuqing Shi, et al.
Prostate Cancer and Prostatic Diseases|March 5, 2022
Liquid biomarkers for early detection of prostate cancer and summary of available data for their use in African-American menGrant M Henning, Gerald L Andriole, Eric H Kim
Prostate Cancer and Prostatic Diseases|March 6, 2022
Prostate arterial chemoembolization for treatment of refractory hematuria and urinary retention in patients with localized advanced prostate cancerMao Qiang Wang, Jin Long Zhang, Feng Duan, et al.
Prostate Cancer and Prostatic Diseases|January 23, 2021
Does prior surgical interventional therapy for BPH affect the oncological or functional outcomes after primary whole-gland prostate cryoablation for localized prostate cancer?Ahmed ElShafei, Molly DeWitt-Foy, Adam Calaway, et al.
Prostate Cancer and Prostatic Diseases|January 28, 2021
Focal therapy compared to radical prostatectomy for non-metastatic prostate cancer: a propensity score-matched studyTaimur T Shah, Deepika Reddy, Max Peters, et al.
Prostate Cancer and Prostatic Diseases|August 29, 2019
Decipher identifies men with otherwise clinically favorable-intermediate risk disease who may not be good candidates for active surveillanceAnnika Herlemann, Huei-Chung Huang, Ridwan Alam, et al.
Prostate Cancer and Prostatic Diseases|February 27, 2019
MEK-ERK signaling is a therapeutic target in metastatic castration resistant prostate cancerNicholas G Nickols, Ramin Nazarian, Shuang G Zhao, et al.
Pageof 199